中國信達(01359.HK)擬分拆信達證券於境內上市
格隆匯 8 月 5日丨中國信達(01359.HK)公佈,公司正考慮可能分拆信達證券及其附屬公司並於中國一家證券交易所獨立上市。信達證券為公司非全資附屬公司,目前主要從事證券經紀、證券承銷與保薦、證券自營業務。
於2020年8月5日,信達證券的建議分拆及上市保薦人向中國證監會北京監管局就展開上市輔導過程遞交申請,尚待取得中國證監會北京監管局的受理函。
根據上市規則第15項應用指引,公司將於適當時候就建議分拆及上市向香港聯交所遞交申請以待批准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.